Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stage (Q42677020)

4 November 2017

title

Decision curve analysis to compare 3 versions of Partin Tables to predict final pathologic stage (English)

1 reference

4 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884254

decision support techniques

23 July 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884254

23 July 2024

Pierre Karakiewicz

1 reference

4 November 2017

Maxine Sun

1 reference

4 November 2017

Herbert Augustin

1 reference

4 November 2017

Hendrik Isbarn

series ordinal

1 reference

4 November 2017

Karl Pummer

series ordinal

1 reference

4 November 2017

Pierre Karakiewicz

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20884254

23 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20884254

23 July 2024

publication date

29 September 2010

1 reference

full work available at URL

4 November 2017

https://api.elsevier.com/content/article/PII:S1078143910001778?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/J.UROLONC.2010.07.003

https://api.elsevier.com/content/article/PII:S1078143910001778?httpAccept=text/plain

23 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/J.UROLONC.2010.07.003

23 July 2024

1 reference

4 November 2017

1 reference

4 November 2017

1 reference

4 November 2017

page(s)

396-401

1 reference

The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Validation of the partin nomogram for prostate cancer in a national sample

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Partin Tables cannot accurately predict the pathological stage at radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

External validation of the updated partin tables in a cohort of French and Italian men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

An updated catalog of prostate cancer predictive tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Decision curve analysis: a novel method for evaluating prediction models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Head to head comparison of three generations of Partin tables to predict final pathological stage in clinically localised prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Indications and contraindications for nerve-sparing radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Decision curve analysis: a discussion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.07.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Seminal vesicle-sparing perineal radical prostatectomy improves early functional results in patients with low-risk prostate cancer

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2010.07.003

23 July 2024

Identifiers

DOI

1 reference

4 November 2017

1 reference